BGM Group acquires Wonder Dragon for RMB550M
Acquisition Details: BGM Group has signed an agreement to acquire 100% of Wonder Dragon Global for RMB550M by issuing 38,165,290 Class A shares at $2 each, with completion expected in Q2 2025.
Strategic Impact: The acquisition enhances BGM Group's healthcare portfolio through Wonder Dragon's premium tea inventory and supports its integration of AI and biopharmaceutical innovations to modernize production and develop medicinal applications.
Trade with 70% Backtested Accuracy
Analyst Views on BGM
About BGM
About the author


U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 150 points, while several companies, including Toro Co, reported better-than-expected quarterly earnings, leading to significant stock price increases.
Notable Stock Gains: Toro Co's shares rose 7% after reporting earnings of 91 cents per share, while DBV Technologies saw a 35.5% increase following positive trial results. Other companies like Udemy and Kodiak Sciences also experienced substantial gains.
Sector Highlights: Cannabis-related stocks surged after reports of potential reclassification of marijuana, with Canopy Growth Corp gaining 16.2%. Lithium-related stocks also rose following the cancellation of mining permits in Yichun.
Company Announcements and Upgrades: Several companies, including Recursion Pharmaceuticals and Two Harbors Investment Corp, saw stock price increases due to upgrades and acquisition announcements, reflecting positive investor sentiment.

U.S. Stock Market Performance: U.S. stocks declined, with the Dow Jones index dropping over 150 points, influenced by significant losses in various companies, particularly Freeport-McMoRan, which fell 16.4% after issuing disappointing sales guidance and reporting fatalities at its mine.
Notable Stock Declines: Other companies also experienced substantial losses, including Zhengye Biotechnology (-28.2%), Harmony Biosciences (-14.6%), and Cohu, Inc. (-12.7%), with Harmony's decline attributed to unmet clinical trial expectations and a lowered price target from Needham.

U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 200 points, while Lyft's shares surged 13.5% following a partnership with Waymo to manage autonomous vehicles in Nashville.
Notable Stock Gains: Several companies experienced significant stock increases, including New Fortress Energy (up 32.3%), Oruka Therapeutics (up 14.1%), and Workday (up 9%) after positive announcements and upgrades.
Financial Results Announcement: BGM Group will release its unaudited financial results for the first half of 2025 on July 24, 2025, before U.S. markets open.
Company Overview: BGM Group focuses on AI applications, intelligent robotics, algorithmic computing, cloud computing, and biopharmaceuticals, integrating AI into their production processes to enhance efficiency and provide customized services in various sectors.

Acquisition Announcement: BGM Group Ltd. has entered into agreements to acquire 100% equity interests in Xingdao Intelligent Cloud Chain and YD Network for a combined valuation of RMB800 million, expected to close by the end of June 2025.
Strategic Expansion: The acquisitions aim to enhance BGM's AI capabilities in both robotics and fintech, allowing for deeper integration of hardware and software, and expanding its multi-agent AI productivity platform across various industries.

Top Performing Mid-Cap Stocks: D-Wave Quantum Inc. saw a 53.47% increase after launching its Advantage2 quantum system, while Regencell Bioscience Holdings and Advance Auto Parts also experienced significant gains of 42.49% and 38.94%, respectively, following positive company announcements.
Other Notable Stock Increases: Merus N.V. rose by 32.68% due to promising clinical trial data, Oklo Inc. gained 29.56% amid regulatory easing reports, and several other mid-cap stocks like Sibanye-Stillwater Limited and BGM Group Ltd. also showed strong performance last week.






